Literature DB >> 9800806

Inaccurate and misleading valve sizing: a proposed standard for valve size nomenclature.

G T Christakis1, K J Buth, B S Goldman, S E Fremes, V Rao, G Cohen, M A Borger, R D Weisel.   

Abstract

BACKGROUND: The sizes with which manufacturers label valves are nonuniform and haphazard. This has led to confusion and inappropriate comparisons of hemodynamics between valves with the same labeled size. Hemodynamic performance of valves is primarily determined by the internal diameter (ID) of their orifice.
METHODS: The purpose of this study was to determine the ID and external diameter of aortic valves used at our institution and compare the measurements to manufacturers' labeled sizes. We also evaluated valve size (ID, manufacturers' labeled size) in 527 patients undergoing isolated aortic valve replacement between 1990 and 1996.
RESULTS: We demonstrated that no two manufacturers' tissue or mechanical valves have the same ID or external diameter for a given labeled size. The labeled size of tissue valves was 1 to 4 mm larger than the measured ID. The labeled size of mechanical valves was 3 to 5 mm larger than the measured ID. The St. Jude HP mechanical valve has a greater ID than all other mechanical valves for each labeled size. Among 403 patients operated on for predominant aortic stenosis, those patients receiving the Toronto Stented Porcine Valve (n = 98) had a larger mean ID (22.3+/-1.9 mm) than 204 patients receiving stented tissue valves (ID = 20.9+/-1.9 mm) and the 101 patients receiving mechanical valves (ID = 19.3+/-1.9 mm, p < 0.0001). However, when the manufacturers' labeled size was used as a measure of the size, the results were greatly exaggerated in favor of the Toronto Stented Porcine Valve (ID = 26.3+/-1.9 mm) compared with stented tissue valves (ID = 23.1+/-2.1) or mechanical valves (ID = 23.6+/-1.9) (p < 0.0001).
CONCLUSIONS: Manufacturers' labeling of valves is nonuniform and may lead to erroneous comparisons and conclusions of hemodynamic differences between valves. We therefore recommend a standardized nomenclature for the size of all valves based on the ID measurement.

Entities:  

Mesh:

Year:  1998        PMID: 9800806     DOI: 10.1016/s0003-4975(98)00758-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Echocardiographically derived effective valve opening area in mitral prostheses: a comparative analysis of various calculations using continuity equation and pressure half time method.

Authors:  Nikola Bogunovic; Dieter Horstkotte; Lothar Faber; Lukas Bogunovic; Frank van Buuren
Journal:  Heart Vessels       Date:  2015-06-07       Impact factor: 2.037

Review 2.  Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses.

Authors:  Dale J Murdoch; John G Webb
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

Review 3.  Current state of transcatheter mitral valve implantation in bioprosthetic mitral valve and in mitral ring as a treatment approach for failed mitral prosthesis.

Authors:  Vratika Agarwal; Ryan K Kaple; Hetal H Mehta; Prabhjot Singh; Vinayak N Bapat
Journal:  Ann Cardiothorac Surg       Date:  2021-09

Review 4.  Transcatheter valve-in-valve therapies: patient selection, prosthesis assessment and selection, results, and future directions.

Authors:  Manuel Wilbring; Konstantin Alexiou; Sems-Malte Tugtekin; Bjoern Sill; Gregor Simonis; Klaus Matschke; Utz Kappert
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 5.  Challenges in valve-in-valve therapy.

Authors:  Alia Noorani; Rahee Radia; Vinayak Bapat
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

6.  Comparable long-term results for porcine and pericardial prostheses after isolated aortic valve replacement.

Authors:  Martin Andreas; Stephanie Wallner; Kurt Ruetzler; Dominik Wiedemann; Marek Ehrlich; Georg Heinze; Thomas Binder; Anton Moritz; Michael J Hiesmayr; Alfred Kocher; Guenther Laufer
Journal:  Eur J Cardiothorac Surg       Date:  2014-12-18       Impact factor: 4.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.